CRCA Performance — ProShares Ultra CRCL
Data updated: 2026-08-14
In the 12 months to May 2026 the fund took in a net $344.9M, and assets reached $227.54M.
CRCA Growth of $100
What $100 invested in ProShares Ultra CRCL grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Trading - Leveraged category average over the same months.
| Period | CRCA | Category average |
|---|---|---|
| Since data start (Aug 2025 – May 2026) | $19 | $125 |
CRCA Trailing Returns
Total returns to May 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +19.99% |
CRCA Annual Returns
Calendar-year total returns of ProShares Ultra CRCL, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–May) | +19.99% |
| 2025 (Aug–Dec) | −83.83% |
CRCA Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | −38.5% | +48.1% | +13.4% | −16.0% | +38.3% | — | — | — | — | — | — | — |
| 2025 | — | — | — | — | — | — | — | −37.2% | −6.9% | −15.9% | −64.2% | −8.1% |
CRCA Risk
Risk measures from monthly returns over Aug 2025 – May 2026.
- Best month: +48.11% (Feb 2026)
- Worst month: −64.23% (Nov 2025)
CRCA Fund Flows
Monthly money in and out of ProShares Ultra CRCL, from SEC Form N-PORT.
- 12-month net flow: $344.9M
- 12-month gross sales (incl. reinvestments): $746.9M
- Sales ÷ redemptions: 1.86×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| May 2026 | $93.7M | $35.2M | $58.6M |
| Apr 2026 | $78.7M | $87.0M | −$8.3M |
| Mar 2026 | $64.2M | $100.9M | −$36.6M |
| Feb 2026 | $44.8M | $55.7M | −$10.9M |
| Jan 2026 | $43.8M | $15.3M | $28.5M |
| Dec 2025 | $53.0M | $12.4M | $40.6M |
| Nov 2025 | $132.0M | $28.6M | $103.5M |
| Oct 2025 | $97.9M | $39.6M | $58.4M |
| Sep 2025 | $61.2M | $16.1M | $45.1M |
| Aug 2025 | $77.5M | $11.4M | $66.1M |
CRCA Assets Under Management
Net assets of ProShares Ultra CRCL by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-05-31 | $227.54M |
| 2026-02-28 | $166.66M |
| 2025-11-30 | $133.55M |
| 2025-08-31 | $52.44M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.